Drug Pipeline

LB-102 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-16 NCT07369154
52-week Open Label Safety-Tolerability Study		 Trial sites expanded: 0 -> 23 locations
Active Studies by Phase
Phase 3
2
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07363577 Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia Schizophrenia Recruiting
NCT07369154 52-week Open Label Safety-Tolerability Study Schizophrenia Not Yet Recruiting
Phase 2
NCT07494305 Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult… Bipolar I Disorder Recruiting
Sponsors Running LB-102 Trials
LB Pharmaceuticals Inc. (3)
Disease Areas
Schizophrenia (2) Bipolar Disorder (1)
Get alerts when LB-102 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free